Biotech, Dividends & New Deals: Market Movers Lighting Up the Pre-Market Tape

September 4, 2025

DENVER, Colo., Sep 04, 2025 (247marketnews.com)- As Wall Street gears up for today’s session, investors are keeping close tabs on biotech updates, dividend news, and a handful of small-cap disruptors making bold strategic plays. Here’s what you need to know this morning as the opening bell approaches:

In a move that signals strong cash flow and shareholder-friendly priorities, BrilliA (NYSE:BRIA), a global solutions provider for the women’s intimate apparel industry, declared a $0.133 per share dividend for its Class A shares. The $2.99M payout will be distributed on September 30, 2025, to holders of record as of September 15. CEO Kendrew Hartanto noted the dividend “reflects strong fundamentals and a disciplined approach to growth.” Expect income-focused investors to take note.

LIXTE Biotechnology (NASDAQ:LIXT) is getting a facelift, both in leadership and location. The oncology-focused biotech announced a major executive restructuring and a move to Boca Raton, Florida, aiming to streamline operations and enhance its development pipeline. With industry veterans experience including Starbucks (NASDAQ:SBUX) and Microsoft (NASDAQ:MSFT), and CEO Geordan Pursglove emphasizing a “fresh perspective,” the company is making a clear push to accelerate its LB-100 anti-cancer program and court potential partners. Keep an eye on LIXT as investors assess the strategic impact of the new C-suite.

Bone Biologics (NASDAQ:BBLG) CEO Jeffrey Frelick issued a detailed letter to shareholders outlining a busy year ahead for Bone Biologics and its lead product candidate NB1, a next-gen spinal fusion treatment combining rhNELL-1 with bone matrix. Key takeaways include:

  • Clinical trial enrollment expected to complete by year-end in Australia.
  • Stability improvements boosted shelf life to 18 months, with a 24-month target in sight.
  • A U.S. patent application was filed to protect NB1’s novel formulation.
  • Interim trial results are expected once patients hit the six-month milestone.

With a recent $5M capital raise and cash runway into Q2 2026, BBLG is one to watch as it advances toward pivotal trials.

Volume in Concorde International (NASDAQ:CIGL) started to tick up in early pre-market trade. The company, which has kept a relatively low profile since its listing, operates in the global infrastructure and construction services sector. Investors are eyeing potential contract wins or M&A signals as catalysts.

HWH International (NASDAQ:HWH), a digital platform provider focused on personal development and wellness, has been hovering near support levels. No new press releases have hit the wire, but market chatter suggests potential collaborations or platform expansions may be in the works. It’s one of those sleeper names that could move quickly on news.

Please go to https://247marketnews.com/lixte-biotechnology/ for further LIXT information and 247marketnews.com LIXT disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (BRIA, LIXT, SBUX, MSFT, BBLG, CIGL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.